Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05875571Phase 4Recruiting
Phase 4, randomised, double-blind trial in postprocedural pain (CPSP) comparing Ketorolac with Placebo (2 arms). Primary endpoint: Post procedural pain after IUD placement at 24 hours. Started Feb 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05875571.